Exact Mass: 519.2482
Exact Mass Matches: 519.2482
Found 500 metabolites which its exact mass value is equals to given mass value 519.2482
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ala Phe Pro Trp
Ala Phe Trp Pro
Ala Ile Met Trp
Ala Ile Trp Met
Ala Leu Met Trp
Ala Leu Trp Met
Ala Met Ile Trp
Ala Met Leu Trp
Ala Met Trp Ile
Ala Met Trp Leu
Ala Pro Phe Trp
Ala Pro Trp Phe
Ala Trp Phe Pro
Ala Trp Ile Met
Ala Trp Leu Met
Ala Trp Met Ile
Ala Trp Met Leu
Ala Trp Pro Phe
Cys Glu Ile Arg
Cys Glu Leu Arg
Cys Glu Arg Ile
Cys Glu Arg Leu
Cys Ile Glu Arg
Cys Ile Arg Glu
Cys Ile Val Trp
Cys Ile Trp Val
Cys Lys Asn Arg
Cys Lys Arg Asn
Cys Leu Glu Arg
Cys Leu Arg Glu
Cys Leu Val Trp
Cys Leu Trp Val
Cys Asn Lys Arg
Cys Asn Arg Lys
Cys Arg Glu Ile
Cys Arg Glu Leu
Cys Arg Ile Glu
Cys Arg Lys Asn
Cys Arg Leu Glu
Cys Arg Asn Lys
Cys Val Ile Trp
Cys Val Leu Trp
Cys Val Trp Ile
Cys Val Trp Leu
Cys Trp Ile Val
Cys Trp Leu Val
Cys Trp Val Ile
Cys Trp Val Leu
Asp Met Arg Val
Asp Met Val Arg
Asp Arg Met Val
Asp Arg Val Met
Asp Ser Trp Ile
Asp Ser Trp Leu
Asp Thr Val Trp
Asp Thr Trp Val
Asp Val Met Arg
Asp Val Arg Met
Asp Val Thr Trp
Asp Val Trp Thr
Asp Trp Ile Ser
Asp Trp Leu Ser
Asp Trp Ser Ile
Asp Trp Ser Leu
Asp Trp Thr Val
Asp Trp Val Thr
Glu Cys Ile Arg
Glu Cys Leu Arg
Glu Cys Arg Ile
Glu Cys Arg Leu
Glu Phe Pro Gln
Glu Phe Gln Pro
Glu Ile Cys Arg
Glu Ile Met Gln
Glu Ile Gln Met
Glu Ile Arg Cys
Glu Leu Cys Arg
Glu Leu Met Gln
Glu Leu Gln Met
Glu Leu Arg Cys
Glu Met Ile Gln
Glu Met Leu Gln
Glu Met Gln Ile
Glu Met Gln Leu
Glu Pro Phe Gln
Glu Pro Gln Phe
Glu Gln Phe Pro
Glu Gln Ile Met
Glu Gln Leu Met
Glu Gln Met Ile
Glu Gln Met Leu
Glu Gln Pro Phe
Glu Arg Cys Ile
Glu Arg Cys Leu
Glu Arg Ile Cys
Glu Arg Leu Cys
Glu Ser Val Trp
Glu Ser Trp Val
Glu Val Ser Trp
Glu Val Trp Ser
Glu Trp Ser Val
Glu Trp Val Ser
Phe Ala Pro Trp
Phe Ala Trp Pro
Phe Glu Pro Gln
Phe Glu Gln Pro
Phe Pro Ala Trp
Phe Pro Glu Gln
Phe Pro Gln Glu
Phe Pro Trp Ala
Phe Gln Glu Pro
Phe Gln Pro Glu
Phe Trp Ala Pro
Phe Trp Pro Ala
His His Ile Asn
His His Leu Asn
His His Asn Ile
His His Asn Leu
His His Gln Val
His His Val Gln
His Ile His Asn
His Ile Asn His
His Leu His Asn
His Leu Asn His
His Asn His Ile
His Asn His Leu
His Asn Ile His
His Asn Leu His
His Gln His Val
His Gln Val His
His Val His Gln
His Val Gln His
Ile Ala Met Trp
Ile Ala Trp Met
Ile Cys Glu Arg
Ile Cys Arg Glu
Ile Cys Val Trp
Ile Cys Trp Val
Ile Asp Ser Trp
Ile Asp Trp Ser
Ile Glu Cys Arg
Ile Glu Met Gln
Ile Glu Gln Met
Ile Glu Arg Cys
Ile His His Asn
Ile His Asn His
Ile Met Ala Trp
Ile Met Glu Gln
Ile Met Gln Glu
Ile Met Trp Ala
Ile Asn His His
Ile Gln Glu Met
Ile Gln Met Glu
Ile Arg Cys Glu
Ile Arg Glu Cys
Ile Ser Asp Trp
Ile Ser Trp Asp
Ile Val Cys Trp
Ile Val Trp Cys
Ile Trp Ala Met
Ile Trp Cys Val
Ile Trp Asp Ser
Ile Trp Met Ala
Ile Trp Ser Asp
Ile Trp Val Cys
Lys Cys Asn Arg
Lys Cys Arg Asn
Lys Met Asn Gln
Lys Met Gln Asn
Lys Asn Cys Arg
Lys Asn Met Gln
Lys Asn Gln Met
Lys Asn Arg Cys
Lys Gln Met Asn
Lys Gln Asn Met
Lys Arg Cys Asn
Lys Arg Asn Cys
Leu Ala Met Trp
Leu Ala Trp Met
Leu Cys Glu Arg
Leu Cys Arg Glu
Leu Cys Val Trp
Leu Cys Trp Val
Leu Asp Ser Trp
Leu Asp Trp Ser
Leu Glu Cys Arg
Leu Glu Met Gln
Leu Glu Gln Met
Leu Glu Arg Cys
Leu His His Asn
Leu His Asn His
Leu Met Ala Trp
Leu Met Glu Gln
Leu Met Gln Glu
Leu Met Trp Ala
Leu Asn His His
Leu Gln Glu Met
Leu Gln Met Glu
Leu Arg Cys Glu
Leu Arg Glu Cys
Leu Ser Asp Trp
Leu Ser Trp Asp
Leu Val Cys Trp
Leu Val Trp Cys
Leu Trp Ala Met
Leu Trp Cys Val
Leu Trp Asp Ser
Leu Trp Met Ala
Leu Trp Ser Asp
Leu Trp Val Cys
Met Ala Ile Trp
Met Ala Leu Trp
Met Ala Trp Ile
Met Ala Trp Leu
Met Asp Arg Val
Met Asp Val Arg
Met Glu Ile Gln
Met Glu Leu Gln
Met Glu Gln Ile
Met Glu Gln Leu
Met Ile Ala Trp
Met Ile Glu Gln
Met Ile Gln Glu
Met Ile Trp Ala
Met Lys Asn Gln
Met Lys Gln Asn
Met Leu Ala Trp
Met Leu Glu Gln
Met Leu Gln Glu
Met Leu Trp Ala
Met Asn Lys Gln
Met Asn Gln Lys
Met Gln Glu Ile
Met Gln Glu Leu
Met Gln Ile Glu
Met Gln Lys Asn
Met Gln Leu Glu
Met Gln Asn Lys
Met Arg Asp Val
Met Arg Val Asp
Met Val Asp Arg
Met Val Arg Asp
Met Trp Ala Ile
Met Trp Ala Leu
Met Trp Ile Ala
Met Trp Leu Ala
Asn Cys Lys Arg
Asn Cys Arg Lys
Asn His His Ile
Asn His His Leu
Asn His Ile His
Asn His Leu His
Asn Ile His His
Asn Lys Cys Arg
Asn Lys Met Gln
Asn Lys Gln Met
Asn Lys Arg Cys
Asn Leu His His
Asn Met Lys Gln
Asn Met Gln Lys
Asn Gln Lys Met
Asn Gln Met Lys
Asn Arg Cys Lys
Asn Arg Lys Cys
Pro Ala Phe Trp
Pro Ala Trp Phe
Pro Glu Phe Gln
Pro Glu Gln Phe
Pro Phe Ala Trp
Pro Phe Glu Gln
Pro Phe Gln Glu
Pro Phe Trp Ala
Pro Gln Phe Glu
Pro Trp Ala Phe
Pro Trp Phe Ala
Gln Glu Phe Pro
Gln Glu Ile Met
Gln Glu Leu Met
Gln Glu Met Ile
Gln Glu Met Leu
Gln Glu Pro Phe
Gln Phe Glu Pro
Gln Phe Pro Glu
Gln His His Val
Gln His Val His
Gln Ile Glu Met
Gln Ile Met Glu
Gln Lys Met Asn
Gln Lys Asn Met
Gln Leu Glu Met
Gln Leu Met Glu
Gln Met Glu Ile
Gln Met Glu Leu
Gln Met Ile Glu
Gln Met Lys Asn
Gln Met Leu Glu
Gln Met Asn Lys
Gln Asn Lys Met
Gln Asn Met Lys
Gln Pro Glu Phe
Gln Pro Phe Glu
Gln Val His His
Arg Cys Glu Ile
Arg Cys Glu Leu
Arg Cys Ile Glu
Arg Cys Lys Asn
Arg Cys Leu Glu
Arg Cys Asn Lys
Arg Asp Met Val
Arg Asp Val Met
Arg Glu Cys Ile
Arg Glu Cys Leu
Arg Glu Ile Cys
Arg Glu Leu Cys
Arg Ile Cys Glu
Arg Ile Glu Cys
Arg Lys Cys Asn
Arg Lys Asn Cys
Arg Leu Cys Glu
Arg Leu Glu Cys
Arg Met Asp Val
Arg Met Val Asp
Arg Asn Cys Lys
Arg Asn Lys Cys
Arg Val Asp Met
Arg Val Met Asp
Ser Asp Ile Trp
Ser Asp Leu Trp
Ser Asp Trp Ile
Ser Asp Trp Leu
Ser Glu Val Trp
Ser Glu Trp Val
Ser Ile Asp Trp
Ser Ile Trp Asp
Ser Leu Asp Trp
Ser Leu Trp Asp
Ser Val Glu Trp
Ser Val Trp Glu
Ser Trp Asp Ile
Ser Trp Asp Leu
Ser Trp Glu Val
Ser Trp Ile Asp
Ser Trp Leu Asp
Ser Trp Val Glu
Thr Asp Val Trp
Thr Asp Trp Val
Thr Val Asp Trp
Thr Val Trp Asp
Thr Trp Asp Val
Thr Trp Val Asp
Val Cys Ile Trp
Val Cys Leu Trp
Val Cys Trp Ile
Val Cys Trp Leu
Val Asp Met Arg
Val Asp Arg Met
Val Asp Thr Trp
Val Asp Trp Thr
Val Glu Ser Trp
Val Glu Trp Ser
Val His His Gln
Val His Gln His
Val Ile Cys Trp
Val Ile Trp Cys
Val Leu Cys Trp
Val Leu Trp Cys
Val Met Asp Arg
Val Met Arg Asp
Val Gln His His
Val Arg Asp Met
Val Arg Met Asp
Val Ser Glu Trp
Val Ser Trp Glu
Val Thr Asp Trp
Val Thr Trp Asp
Val Trp Cys Ile
Val Trp Cys Leu
Val Trp Asp Thr
Val Trp Glu Ser
Val Trp Ile Cys
Val Trp Leu Cys
Val Trp Ser Glu
Val Trp Thr Asp
Trp Ala Phe Pro
Trp Ala Ile Met
Trp Ala Leu Met
Trp Ala Met Ile
Trp Ala Met Leu
Trp Ala Pro Phe
Trp Cys Ile Val
Trp Cys Leu Val
Trp Cys Val Ile
Trp Cys Val Leu
Trp Asp Ile Ser
Trp Asp Leu Ser
Trp Asp Ser Ile
Trp Asp Ser Leu
Trp Asp Thr Val
Trp Asp Val Thr
Trp Glu Ser Val
Trp Glu Val Ser
Trp Phe Ala Pro
Trp Phe Pro Ala
Trp Ile Ala Met
Trp Ile Cys Val
Trp Ile Asp Ser
Trp Ile Met Ala
Trp Ile Ser Asp
Trp Ile Val Cys
Trp Leu Ala Met
Trp Leu Cys Val
Trp Leu Asp Ser
Trp Leu Met Ala
Trp Leu Ser Asp
Trp Leu Val Cys
Trp Met Ala Ile
Trp Met Ala Leu
Trp Met Ile Ala
Trp Met Leu Ala
Trp Pro Ala Phe
Trp Pro Phe Ala
Trp Ser Asp Ile
Trp Ser Asp Leu
Trp Ser Glu Val
Trp Ser Ile Asp
Trp Ser Leu Asp
Trp Ser Val Glu
Trp Thr Asp Val
Trp Thr Val Asp
Trp Val Cys Ile
Trp Val Cys Leu
Trp Val Asp Thr
Trp Val Ile Cys
Trp Val Leu Cys
WYE-125132(WYE-132)
WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2. WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2.
1-palmitoyl-sn-glycero-3-phospho-l-serine sodium salt
Pefcalcitol
C78284 - Agent Affecting Integumentary System > C29708 - Anti-psoriatic Agent
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-azaniumyl-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate
N-[(4R,7R,8R)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7R,8R)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methylimidazole-4-sulfonamide
N-[(4S,7S,8R)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7S,8R)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methylimidazole-4-sulfonamide
N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methylimidazole-4-sulfonamide
N-[(4S,7S,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
3-(4-fluorophenyl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4R,7R,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
3-(4-fluorophenyl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
3-(4-fluorophenyl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
(4Z,7Z,16S,17R,19Z)-16-({(2R)-2-azaniumyl-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-17-hydroxydocosa-4,7,10,12,14,19-hexaenoate
(3S)-1-[2-[2,2,2-tris(4-methoxyphenyl)ethoxy]ethyl]-3-piperidinecarboxylic acid
2-amino-3-[hydroxy-[2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]phosphoryl]oxypropanoic acid
(13R)-glycinylcystein-S-yl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)
A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.
16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the alpha-amino group of 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid; major species at pH 7.3.
KT185
KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells[1].